ArticlebioRxiv : the preprint server for biology2026
Beyond gene length: Exon-intron architecture and isoform potential in the evolution of eukaryotic complexity.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Alternative splicing is a major source of human transcriptomic and phenotypic variation, yet its evolutionary contribution to genomic complexity remains unresolved. It has been shown that a mean gene length can be the most basic but remarkably efficient proxy for multicellular genome complexity, whereas mean protein length is not, as it plateaus abruptly early in eukaryotic evolution. Here, we show that, across 2,683 genomes, exon count continues to increase beyond this transition and then rapidly saturates at ~10 exons per gene, supporting its role as an additional dimension of genomic complexity linked to exon-intron architecture. A simple stochastic exon-splitting model reproduces the observed biphasic exon-number growth pattern and identifies minimal exon length as a key determinant.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.